Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
2.95M
-
Shares change
-
-102K
-
Total reported value, excl. options
-
$937K
-
Value change
-
-$47.9K
-
Put/Call ratio
-
0.21
-
Number of buys
-
11
-
Number of sells
-
-8
-
Price
-
$0.32
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2022
30 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q4 2022.
IGC Pharma, Inc. - COM NEW (IGC) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.95M shares
.
Largest 10 shareholders include BlackRock Inc. (756K shares), VANGUARD GROUP INC (647K shares), GEODE CAPITAL MANAGEMENT, LLC (302K shares), RENAISSANCE TECHNOLOGIES LLC (222K shares), STATE STREET CORP (184K shares), MILLENNIUM MANAGEMENT LLC (145K shares), DEARBORN PARTNERS LLC (134K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (78.1K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (69K shares), and GOLDMAN SACHS GROUP INC (65.5K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.